Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Total Current Liabilities (2019 - 2025)

Historic Total Current Liabilities for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to $58.8 million.

  • IDEAYA Biosciences' Total Current Liabilities rose 2766.17% to $58.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $58.8 million, marking a year-over-year increase of 2766.17%. This contributed to the annual value of $58.8 million for FY2025, which is 2766.17% up from last year.
  • According to the latest figures from Q4 2025, IDEAYA Biosciences' Total Current Liabilities is $58.8 million, which was up 2766.17% from $64.5 million recorded in Q3 2025.
  • IDEAYA Biosciences' Total Current Liabilities' 5-year high stood at $64.5 million during Q3 2025, with a 5-year trough of $24.9 million in Q3 2023.
  • Over the past 5 years, IDEAYA Biosciences' median Total Current Liabilities value was $39.6 million (recorded in 2021), while the average stood at $41.2 million.
  • As far as peak fluctuations go, IDEAYA Biosciences' Total Current Liabilities soared by 39181.87% in 2021, and later crashed by 5638.24% in 2023.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Total Current Liabilities stood at $45.2 million in 2021, then fell by 29.76% to $31.7 million in 2022, then dropped by 14.56% to $27.1 million in 2023, then surged by 70.0% to $46.1 million in 2024, then increased by 27.66% to $58.8 million in 2025.
  • Its Total Current Liabilities stands at $58.8 million for Q4 2025, versus $64.5 million for Q3 2025 and $55.3 million for Q2 2025.